- Home
- ESP vs TNXP Comparison
ESP vs TNXP Comparison
Compare ESP & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- TNXP
- Stock Information
- Founded
- ESP 1928
- TNXP 2007
- Country
- ESP United States
- TNXP United States
- Employees
- ESP N/A
- TNXP N/A
- Industry
- ESP Industrial Machinery/Components
- TNXP Biotechnology: Pharmaceutical Preparations
- Sector
- ESP Technology
- TNXP Health Care
- Exchange
- ESP Nasdaq
- TNXP Nasdaq
- Market Cap
- ESP 84.1M
- TNXP 71.6M
- IPO Year
- ESP N/A
- TNXP N/A
- Fundamental
- Price
- ESP $27.30
- TNXP $18.18
- Analyst Decision
- ESP
- TNXP Strong Buy
- Analyst Count
- ESP 0
- TNXP 2
- Target Price
- ESP N/A
- TNXP $585.00
- AVG Volume (30 Days)
- ESP 13.6K
- TNXP 2.6M
- Earning Date
- ESP 05-12-2025
- TNXP 03-18-2025
- Dividend Yield
- ESP 3.67%
- TNXP N/A
- EPS Growth
- ESP 31.14
- TNXP N/A
- EPS
- ESP 2.45
- TNXP N/A
- Revenue
- ESP $43,917,522.00
- TNXP $10,094,000.00
- Revenue This Year
- ESP N/A
- TNXP $84.08
- Revenue Next Year
- ESP N/A
- TNXP $126.94
- P/E Ratio
- ESP $11.12
- TNXP N/A
- Revenue Growth
- ESP 18.62
- TNXP 29.94
- 52 Week Low
- ESP $20.20
- TNXP $6.76
- 52 Week High
- ESP $33.00
- TNXP $672.00
- Technical
- Relative Strength Index (RSI)
- ESP 54.27
- TNXP 48.95
- Support Level
- ESP $26.63
- TNXP $12.80
- Resistance Level
- ESP $27.75
- TNXP $31.87
- Average True Range (ATR)
- ESP 0.60
- TNXP 4.30
- MACD
- ESP 0.17
- TNXP 0.57
- Stochastic Oscillator
- ESP 76.44
- TNXP 22.53
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.